Characteristic | N | % |
---|---|---|
Total Patients | 31 | 100% |
Patient sex | ||
Male | 13 | 42% |
Women | 18 | 58% |
Primary Site | ||
Non-small Cell Lung | 9 | 16% |
Sarcoma | 5 | 9% |
Breast | 4 | 7% |
Head and Neck | 4 | 7% |
Colon | 4 | 7% |
Small Cell Lung | 3 | 5% |
Basal Cell | 1 | 2% |
Ovarian | 1 | 2% |
Metastatic Sites | ||
Lung | 19 | 33% |
Lymph Node | 11 | 19% |
Osseous | 11 | 19% |
Liver | 9 | 16% |
Adrenal | 6 | 10% |
Soft tissue | 2 | 3% |
Dose | ||
24 Gray | 19 | 33% |
30 Gray | 20 | 35% |
36 Gray | 8 | 14% |
42 Gray | 9 | 16% |
50 Gray | 2 | 3% |